Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04716413 · ClinicalTrials.gov registry record · Phase 4
Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04716413 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT04716413, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.
Interventions
- DRUG Dsuvia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2022-11-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04716413
The ClinicalTrials.gov registry entry for NCT04716413 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dsuvia is the first listed.
NCT04716413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04716413 about?
NCT04716413 is a clinical study titled "Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment". In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.
What is the current status of trial NCT04716413?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2021-09-27. Estimated completion is 2022-11-18.
What interventions are being tested in trial NCT04716413?
The interventions under investigation include: Dsuvia (DRUG).
Who is sponsoring clinical trial NCT04716413?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.